Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 05, 2021

SELL
$72.25 - $168.95 $5.72 Million - $13.4 Million
-79,191 Closed
0 $0
Q4 2020

Feb 02, 2021

BUY
$125.56 - $178.74 $5.12 Million - $7.29 Million
40,763 Added 106.08%
79,191 $13.5 Million
Q3 2020

Oct 30, 2020

SELL
$127.12 - $172.34 $825,517 - $1.12 Million
-6,494 Reduced 14.46%
38,428 $5.4 Million
Q2 2020

Aug 05, 2020

SELL
$93.0 - $171.7 $19,809 - $36,572
-213 Reduced 0.47%
44,922 $7.2 Million
Q1 2020

May 05, 2020

BUY
$82.38 - $131.64 $3.72 Million - $5.94 Million
45,135 New
45,135 $4.42 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.